Global Dementia Care Products Market Size, Forecast, and Trend Highlights Over 2025-2037
Dementia Care Products Market size was valued at USD 31.5 million in 2024 and is expected to cross USD 72.5 million by 2037, expanding at more than 7.2% CAGR during the forecast period, i.e., 2025-2037. In 2025, the industry size of the dementia care products is estimated to be at USD 33.7 million.
As per the World Economic Forum, the number of people living with dementia across the globe surpassed 55.0 million in 2023, presenting a year-on-year emergence of over 10.0 million new cases. This figure is further poised to reach 78.0 million by 2030 and 139.0 million by 2050, attributable to the aging population and unhealthy lifestyles (Alzheimer’s Disease International). On the other hand, a WHO projection concluded the volume of the world’s older habitats, aged 60 and over, to be 2.1 billion by 2050. One of the most common types of this neurological disorder is Alzheimer's disease, constituting 60-70% of the total dementia cases worldwide: WHO report 2025. These demographics represent a large and continuously growing consumer base for this sector.
A wide range of pipelines incorporating daily reminder tools, communication-aided solutions, personal safety accommodations, and memory exercise devices are availed by the dementia care products market to tackle this widespread issue. The cost-effectiveness and improved utilization of these commodities across the globe are intended to create enhanced sales opportunities. The increased acceptance of healthcare advances and online shopping trends are also contributing to inflating demand for this merchandise. For instance, Brain+ calculated its UK-based addressable CST-Assistant market to be valued at USD 220.9 million by the end of the 2024 fiscal year. The company further shared its plans of expanding its global commercial penetration to generate more profitable revenues.
Dementia Care Products Sector: Growth Drivers and Challenges
Growth Drivers
- Growing advances and awareness in early diagnosis: Being a progressive disease, dementia is now dragging focus toward prevention and preliminary management. Several public and private organizations are engaging their resources to spread education about the importance of diagnosis at an early stage, escalating adoption in the dementia care products market. For instance, in March 2023, Samsung collaborated with Bottneuro AG to escalate its capabilities in enhancing the detection and treatment of Alzheimer’s residents. Both entities put their efforts into making the Samsung Galaxy Tab S8+ 5G Enterprise Edition compatible with Bottneuro’s 3D MRI and PET imaging technologies, empowering the user-friendliness of the digital diagnostic solutions.
- Initiatives and innovations to improve accessibility: The dementia care products market is predicted to witness robust expansion through the improving availability of various advanced options. Additionally, the development of new solutions caters to the portfolio extension and upliftment of convenience for customers & service providers worldwide. In support of such technological integration, in October 2022, the Greater London Authority and the London Office for Technology and Innovation (LOTI) collaboratively launched an online dementia care toolkit, accelerating the Digital Inclusion Innovation Programme. This Tap and Chat digital befriending accessory is designed to increase the engagement of inexperienced Zoom users.
Challenges
- Limitations in widespread adoption: Despite the enlarging patient pool and efforts in increasing accessibility, the dementia care products market still lacks continuous progression. There is a cohort of issues related to affordability, universal standardization, the availability of skilled caregivers, and the supply-demand chain. These disruptions have the potential to hinder the consistency in the business flow, discouraging both new entrants and patients from investing in this sector.
- Rising economic burden of healthcare: The expensiveness of first-line treatment and diagnosis for such complex neurodegenerative disorders is already fostering a financial pressure on consumers. This often creates hesitation among the caregivers and neurologists from suggesting and prescribing supportive tools available in the market. Additionally, a majority of the consumer base belongs to the low- and middle-income countries, making it hard to penetrate advancements globally.
Dementia Care Products Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
7.2% |
|
Base Year Market Size (2024) |
USD 31.5 million |
|
Forecast Year Market Size (2037) |
USD 72.5 million |
|
Regional Scope |
|
Dementia Care Products Segmentation
Product Type (Personal Safety Products, Daily Reminder Products, Memory Exercise & Activity Products, Dining Aids, Bathroom Safety Products, Communication Products)
Based on product type, the memory exercise & activity products segment is poised to lead the global dementia care products market by 2037. These offerings are widely used as a primary treatment of associated neurological impairment. They help in enhancing memory and in controlling the overall activity of the body, making this segment more popular and attractive for investors and participants. For instance, in May 2024, Cadbury commercially distributed Memory Bar Boxes to fulfill the aim of its partnership with Alzheimer’s Research UK. The dedicated pipeline included six limited-edition retro Dairy Milk bars specifically designed to stimulate conversation and initiate memory activities for individuals with dementia.
End user (Long Term Care Centers, Home Care Settings)
In terms of end user, the home care settings segment is projected to propagate the dementia care products market with a notable CAGR throughout the assessed timeframe. Several studies have shown the importance of patient’s comfort and family involvement in procuring better results in neurology-related ailments. In addition, the rising cost of hospitalization is also propelling the adoption of remote healthcare, particularly in emerging marketplaces, making this segment a target discipline for global leaders. On this note, the Healthcare Federation of India reported that senior citizens across the nation accounted for 60-80% of the total demand for long-term home care. This category of medical settings was further estimated to garner USD 5.4 billion in 2022, with a potential of generating USD 19.9 billion by 2025.
Our in-depth analysis of the global dementia care products market includes the following segments:
|
Product Type |
|
|
End user |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportDementia Care Products Industry - Regional Synopsis
North American Market Forecast 
North America is poised to dominate the dementia care products market with a share of 38.1% over the analyzed timeline. The presence of numerous suppliers in the region, coupled with the high healthcare availability, is fueling its proprietorship. This prosperous scenario is backed by meticulous government initiatives and improved reimbursement policies. For instance, in July 2024, the Centers for Medicare & Medicaid Services (CMS) secured more than 400 registrations for participation in the Guiding an Improved Dementia Experience (GUIDE) Model. This was a milestone in affiliating a strong public access to complete services and support, covering from clinical to non-clinical necessities.
The U.S. is augmenting the dementia care products market with a lucrative business environment built with a favorable regulatory framework and influential economic support. On this note, in April 2025, PocketRN signed a national partnership with Homewatch CareGivers to support the motive of CMS’s alternative payment ecosystem, the GUIDE Model. Both entities made a strategic move to leverage their daily and respite care portfolios across the nation by captivating a larger audience consisting of caregivers and dementia patients seeking economically suitable options.
APAC Market Forecast 
Asia-Pacific is anticipated to be the fastest growing region in the dementia care products market on the back of increasing patient population. Additionally, with a blend of R&D excellence and MedTech emergence, technologically developed countries such as Japan, Singapore, and South Korea are discovering more efficient detection and curative methods. For instance, in February 2025, Gray Matter Solutions partnered with Osler Group to develop an affordable and effective AI-powered diagnostic tool to identify early-stage dementia. Such innovations in screening are promoting early detection and preventive approaches by mitigating the challenges in economic disparity and disease complexity.
Japan is a globally leading hub of innovations in the dementia care products market. Approximately 5.2 million citizens in this country are predicted to develop this neurodegenerative disorder by 2030. This pushed the governing authorities to engage maximum national assets, including technological advances, in fighting this epidemic. For instance, in January 2024, the Basic Act on Dementia to Promote an Inclusive Society was implemented to cultivate a supportive atmosphere for this patient pool, promoting development in personal care solutions.
Companies Dominating the Dementia Care Products Landscape
- Best Alzheimer's Products
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Healthcare Products LLC
- EasierLiving, LLC
- Parentgiving, Inc.
- Find Memory Care
- NRS Healthcare
- Buddi Ltd.
- Brain+ A/S
- Homewatch CareGivers
- Harmonic Health
- CareYaya Health Technologies
The dementia care products market is projected to witness remarkable progress, owing to the high availability of various commodities and continuous innovations originating from frequent R&D activities of various key players. They are uplifting the scale of their global operations by introducing creative solutions. Furthermore, their commercial success is attracting and inspiring more companies to engage in globalization, fostering new business opportunities. For instance, in March 2025, Brain+ successfully pushed revenue generation from the total sales pipeline of Ayla to USD 547684.1 since its inception in the UK. The company further shared its plans to secure a net annual recurring revenue (ARR) of USD 1.0 million till the end of the 2025 fiscal year. Such key players are:
In the News
- In October 2024, Brain+ announced the commercial launch of its revolutionary medical device software, Ayla- your CST Assistant, in the UK after getting marketing clearance from the regulatory framework. This certified digital solution is specifically designed to assist dementia therapists and clinicians in offering scalable and high-quality delivery of cognitive stimulation therapy (CST).
- In October 2024, CareYaya introduced AI-powered smart glasses in integration with its large language model, MedaCareLLM, to enable patients with real-time assistance and early dementia screening. The platform features facial & object recognition, medication reminders, and caregiver support by processing multimodal datasets of cognitive and neurological data collected through the glasses.
Author Credits: Radhika Pawar
- Report ID: 1105
- Published Date: Apr 10, 2025
- Report Format: PDF, PPT
